Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries India Globalization Capital Inc (NY: IGC ) 0.3690 -0.0063 (-1.68%) Official Closing Price Updated: 8:00 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about India Globalization Capital Inc < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Preclinical Research Evaluating New Molecule IGC-1C in Treatment of Alzheimer’s Disease August 22, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Announces Research Demonstrating New Molecule IGC-1C Targets Tau Protein in Alzheimer's Disease August 22, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc.’s (NYSE American: IGC) AI-Driven Approach Reveals ‘Promising Opportunity’ for IGC-1A to Be a Potential GLP-1 Agonist August 20, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Expands Drug Portfolio to Metabolic Disorders with IGC-1A, A Potential New GLP-1 Agonist August 20, 2024 From IGC Pharma Via Business Wire IGC Stock Earnings: IGC Pharma Beats EPS, Misses Revenue for Q1 2025 August 12, 2024 IGC stock results show that IGC Pharma beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2025. Via InvestorPlace BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Q1 2025 Financial, Operational Results Report August 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property IGC Pharma Revenue Declines 51% YoY Due To Completion Of Its Legacy Project In India, Highlights Important Milestones In Alzheimer's Research August 09, 2024 Via Benzinga IGC Pharma Reports First Quarter Fiscal 2025 Results August 08, 2024 From IGC Pharma, Inc. Via Business Wire InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Receives ‘Buy’ Recommendation in AGP’s Analyst Coverage Research Report July 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Equity Analyst Coverage by Alliance Global Partners (AGP) with a "Buy" Recommendation and $3.50 Price Target July 18, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc.’s (NYSE American: IGC) TGR-63 Demonstrates Blood-Brain Barrier Permeability in Preliminary Findings July 09, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence Preclinical Analyses of TGR-63 Demonstrate Blood-Brain Barrier Permeability and Safety Profile July 09, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Releases Positive Data from TGR-63 Preclinical Studies June 26, 2024 Via Investor Brand Network Topics Artificial Intelligence Intellectual Property Exposures Artificial Intelligence Intellectual Property InvestorNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Releases Financial Report for Fiscal Year June 25, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma's TGR-63 Preclinical Results Show Substantial Reduction in Amyloid Plaque, a Key Hallmark of Alzheimer's Disease June 25, 2024 From IGC Pharma, Inc. Via Business Wire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday June 25, 2024 Pre-market stock movers are worth checking out on Tuesday as we get into all of the hottest news worth reading about this morning! Via InvestorPlace IGC Stock Earnings: IGC Pharma Meets EPS, Beats Revenue for Q4 2024 June 24, 2024 IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. Via InvestorPlace IGC Reports Financial Results for Fiscal Year Ended March 31, 2024 June 24, 2024 From IGC Pharma, Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Execs Slated to Present at Upcoming Ascendiant Capital Markets Event June 18, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets June 18, 2024 From IGC Pharma, Inc. Via Business Wire Hedge Fund Settles At $2.25M With SEC For Exposed Short Seller Deal, 2 Cannabis Stocks Affected June 13, 2024 Discover how Anson Funds settled with the SEC for $2.25M over an undisclosed collaboration with short seller impacting cannabis stocks Via Benzinga Topics Cannabis Regulatory Compliance Exposures Cannabis Legal Regulatory 12 Health Care Stocks Moving In Tuesday's Pre-Market Session June 11, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Announces Publication of Key Study in European Journal June 10, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Publishes Study in European Society of Medicine Investigating the Impact of CYP2C9 Genetic Polymorphism on Pharmacokinetics of Delta 9 Tetrahydrocannabinol June 10, 2024 From IGC Pharma, Inc. Via Business Wire 12 Health Care Stocks Moving In Tuesday's After-Market Session June 04, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 31, 2024 Via Benzinga BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Initiates Patient Enrollment in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma Announces Patient Enrollment at Neurostudies in Phase 2 Trial Investigating IGC-AD1 May 28, 2024 From IGC Pharma Inc. Via Business Wire BioMedNewsBreaks — IGC Pharma Inc. (NYSE American: IGC) Management Hosting Meetings at Upcoming BIO International Convention 2024 May 22, 2024 Via Investor Brand Network Topics Artificial Intelligence Exposures Artificial Intelligence IGC Pharma to Attend BIO International Convention 2024 May 21, 2024 From IGC Pharma Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.